Protocol Specific Research Support
协议特定研究支持
基本信息
- 批准号:8180663
- 负责人:
- 金额:$ 6.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:BackCancer CenterChargeClinicalClinical InvestigatorClinical ProtocolsClinical ResearchClinical TrialsCollaborationsCommunitiesDataData CollectionEnsureEvaluationFinancial SupportFoundationsFundingGiftsGoalsIndividualInformaticsLaboratoriesLeadMalignant NeoplasmsMeasuresMedicalMonitorNew MexicoNursing ResearchOncologistPatient CarePatientsPeer ReviewPhasePhysician ExecutivesPilot ProjectsProcessProductivityProtocols documentationResearch ActivityResearch Ethics CommitteesResearch PersonnelResearch SupportResourcesReview CommitteeSystemTaxesTestingTobaccoTranslational ResearchUniversitiesbasecancer carecancer therapydata managementdesigninformatics shared resourceinnovationmeetingsmemberpreventprogramstumorworking group
项目摘要
The Protocol Specific Research Support (PSRS) of the UNM Cancer Center functions to support early phase investigator-initiated pilot studies that lack sponsored support. Early phase unsupported investigator-initiated clinical trials are proposed at the Clinical Working Group level, and reviewed by the Protocol Review Committee (at UNM termed the Medical and Scientific Review Committee) for scientific merit. Should they be approved at this level, and lack support, they are submitted to the Clinical Research Committee for consideration of institutional support. This PSRS review is chaired by C. Verschraegen, MD, the member of the Clinical Research Committee responsible for organizing PSRS evaluations. Should the unsupported protocols be deemed worthy of support, they are then submitted to an appropriate IRB, and if approved, implemented by the Clinical Protocol, Data Management, and Informatics Shared Resource with protocol specific financial support. The PSRS research nurse is M. Pruess, and the data manager is M. Allred. In FY 2008/9 there were 19 investigator-initiated Phase l-lll interventional clinical trials that required UNM Cancer Center support. These trials accrued 222 total patients in the FY 2008/9. In FY 2008/9 there were 11 investigator-initiated phase I or l/ll interventional clinical trials that were supported by the UNM Cancer Center. These trials accrued 52 total patients. These trials were innovative pilot projects that were designed to lead to larger externally supported later phase clinical trials. This significant UNM Cancer Center support of early phase investigator-initiated clinical trials demonstrates an active Protocol Specific Research Support program.
UNM癌症中心功能的方案特定研究支持(PSRS)支持没有赞助支持的早期研究者发起的试点研究。早期阶段不支持研究者发起的临床试验在临床工作组层面提出,并由协议审查委员会(UNM指定的医学和科学审查委员会)进行审查,以供科学功绩进行审查。如果他们在此级别批准并缺乏支持,则将其提交给临床研究委员会以考虑机构支持。该PSRS审查由负责组织PSRS评估的临床研究委员会成员C. Verschraegen主持。如果不支持的协议被认为值得支持,则将其提交给适当的IRB,如果获得临床协议,数据管理和Informatics Informatics共享资源的批准,并具有特定于协议的财务支持。 PSRS研究护士是M. Pruess,数据经理是M. Allred。在2008/9财年,有19个研究者发入的L-LLL介入临床试验需要UNC癌症中心支持。这些试验在2008/9财年累计222例患者。在2008/9财年,有11期研究员发入的I期或LL/LL介入临床试验得到了UNM癌症中心的支持。这些试验累积了52例患者。这些试验是创新的试点项目,旨在导致更大的外部支持后期临床试验。早期研究者发起的临床试验的这一重要的联合国癌症中心支持表明了一项主动方案特定的研究支持计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Claire F. Verschraegen其他文献
Prognosis of hepatoid yolk sac tumor in women: what's up, Doc?
- DOI:
10.1016/j.ejogrb.2013.12.029 - 发表时间:
2014-04-01 - 期刊:
- 影响因子:
- 作者:
Kristsanamon Rittiluechai;Rebecca Wilcox;Jennifer Lisle;Elise Everett;H. James Wallace;Claire F. Verschraegen - 通讯作者:
Claire F. Verschraegen
Claire F. Verschraegen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Claire F. Verschraegen', 18)}}的其他基金
Training Hematology and Oncology Fellows in Clinical Research
培训血液学和肿瘤学研究员进行临床研究
- 批准号:
10434663 - 财政年份:2020
- 资助金额:
$ 6.3万 - 项目类别:
Training Hematology and Oncology Fellows in Clinical Research
培训血液学和肿瘤学研究员进行临床研究
- 批准号:
10675683 - 财政年份:2020
- 资助金额:
$ 6.3万 - 项目类别:
CLINICAL PROTOCOL, DATA MANAGEMENT, AND INFORMATICS
临床方案、数据管理和信息学
- 批准号:
7127433 - 财政年份:2005
- 资助金额:
$ 6.3万 - 项目类别:
NM Minority Based Community Clinical Oncology Program
新墨西哥州少数民族社区临床肿瘤学计划
- 批准号:
7122049 - 财政年份:2000
- 资助金额:
$ 6.3万 - 项目类别:
New Mexico Minority-Based Community Clinical Oncology Program
新墨西哥州少数民族社区临床肿瘤学计划
- 批准号:
7643448 - 财政年份:2000
- 资助金额:
$ 6.3万 - 项目类别:
NM Minority Based Community Clinical Oncology Program
新墨西哥州少数民族社区临床肿瘤学计划
- 批准号:
7266274 - 财政年份:2000
- 资助金额:
$ 6.3万 - 项目类别:
New Mexico Minority-Based Community Clinical Oncology Program
新墨西哥州少数民族社区临床肿瘤学计划
- 批准号:
7473432 - 财政年份:2000
- 资助金额:
$ 6.3万 - 项目类别:
ORAL 9 NITROCAMPTOTHECIN IN PATIENTS WITH ADVANCED MULLERIAN CANCER
晚期苗勒管癌患者口服 9 硝基喜树碱
- 批准号:
6309258 - 财政年份:1999
- 资助金额:
$ 6.3万 - 项目类别:
ORAL 9 NITROCAMPTOTHECIN IN PATIENTS WITH ADVANCED MULLERIAN CANCER
晚期苗勒管癌患者口服 9 硝基喜树碱
- 批准号:
6121116 - 财政年份:1998
- 资助金额:
$ 6.3万 - 项目类别:
9 NITRO 20 CAMPTOTHECIN PROPIONATE IN PTS W/ ADVANCED MALIGNANCIES
9 硝基 20 喜树碱丙酸酯治疗患有晚期恶性肿瘤的 PTS
- 批准号:
6265672 - 财政年份:1998
- 资助金额:
$ 6.3万 - 项目类别:
相似国自然基金
以家庭为中心的癌症患儿多症状管理模式的构建及干预:基于症状管理理论的实证研究
- 批准号:71704106
- 批准年份:2017
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Flow Cytometry and Confocal Microscopy Shared Resource
流式细胞术和共焦显微镜共享资源
- 批准号:
10625766 - 财政年份:2023
- 资助金额:
$ 6.3万 - 项目类别:
Receptor-Targeted Fluorescence-Guided Surgery in Pancreatic Neuroendocrine Tumors
胰腺神经内分泌肿瘤受体靶向荧光引导手术
- 批准号:
10522096 - 财政年份:2022
- 资助金额:
$ 6.3万 - 项目类别:
Receptor-Targeted Fluorescence-Guided Surgery in Pancreatic Neuroendocrine Tumors
胰腺神经内分泌肿瘤受体靶向荧光引导手术
- 批准号:
10654865 - 财政年份:2022
- 资助金额:
$ 6.3万 - 项目类别: